Illumina on Tuesday unveiled what it calls the world’s largest functional cell dictionary that, when paired with artificial ...
The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest ...
Under an alliance framework with AstraZeneca, Merck, and Eli Lilly and Company leading as founding participants, the Atlas is ...
Pharmaceutical Technology on MSN
JPM26: Illumina debuts billion cell atlas to drive AI-driven drug discovery
The Billion Cell Atlas, backed by Eli Lilly, MSD and AstraZeneca, maps mechanisms to support informed drug discovery.
A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...
Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery ...
The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...
A newly developed immune cell atlas uses insights into how the immune system interacts with cancer cells to determine how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback